Ciprofloxacin and CAPD peritonitis.
Ludlam
H A
HA
Dryden
M S
MS
Phillips
I
I
D002939:Ciprofloxacin / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D008826:Microbial Sensitivity Tests; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy*; D012074:Remission Induction; D013203:Staphylococcal Infections / Q000188:drug therapy*
D002939:Ciprofloxacin